$LIMN Up 53% Premarket! 🚀 🔹 Big move as momentum traders jump into this beaten-down biotech setup 📈 🔹 Liminatus Pharma is developing immune-modulating cance

$LIMN Up 53% Premarket! 🚀 🔹 Big move as momentum traders jump into this beaten-down biotech setup 📈 🔹 Liminatus Pharma is developing immune-modulating cancer therapies focused on next-gen oncology treatment 🧬 🔹 Recent financing headlines and Nasdaq compliance updates keeping the stock on watch…